|
Volumn 25, Issue 12, 2017, Pages 2946-2955
|
Design, synthesis, and evaluation of multitarget-directed ligands against Alzheimer's disease based on the fusion of donepezil and curcumin
|
Author keywords
AChE inhibition; Alzheimer's disease; A 1 42 self aggregation; Curcumin derivatives
|
Indexed keywords
1 (3 HYDROXY 4 METHOXYPHENYL) 2 [2 [1 (3 METHYLBENZYL)PIPERIDIN 4 YL]ETHYL]BUTANE 1,3 DIONE;
1 (3 HYDROXY 4 METHOXYPHENYL) 4 [1 (3 METHYLBENZYL)PIPERIDIN 4 YL]BUTANE 1,3 DIONE;
1 (3 METHOXYPHENYL) 2 [2 [1 (3 METHYLBENZYL)PIPERIDIN 4 YL]ETHYL]BUTANE 1,3 DIONE;
1 (3,4 DIMETHOXYPHENYL) 2 [2 [1 (3 METHYLBENZYL)PIPERIDIN 4YL]ETHYL]BUTANE 1,3 DIONE;
1 (4 HYDROXY 3 METHOXYPHENYL) 2 [2 [1 (3 METHYLBENZYL)PIPERIDIN 4 YL]ETHYL]BUTANE 1,3 DIONE;
1 [3 METHOXY 4 (METHOXYMETHOXY)PHENYL] 2 [2 [1 (3 METHYLBENZYL)PIPERIDIN 4 YL]ETHYL]BUTANE 1,3 DIONE;
1 [4 METHOXY 3 (METHOXYMETHOXY)PHENYL] 2 [2 [1 (3 METHYLBENZYL)PIPERIDIN 4 YL]ETHYL]BUTANE 1,3 DIONE;
1 [4 METHOXY 3 (METHOXYMETHOXY)PHENYL] 4 [1 (3 METHYLBENZYL)PIPERIDIN 4 YL]BUTANE 1,3 DIONE;
2 [(1 BENZYLPIPERIDIN 4 YL)METHYL] 1 (3 METHOXYPHENYL)BUTANE 1,3 DIONE;
2 [(1 BENZYLPIPERIDIN 4 YL)METHYL] 1 (3,4 DIMETHOXYPHENYL)BUTANE 1,3 DIONE;
2 [2 (1 BENZYLPIPERIDIN 4 YL)ETHYL] 1 (3,4 DIMETHOXYPHENYL)BUTANE 1,3 DIONE;
2 [2 (1 BENZYLPIPERIDIN 4 YL)ETHYL] 1 (4 HYDROXY 3 METHOXYPHENYL)BUTANE 1,3 DIONE;
2 [2 (1 BENZYLPIPERIDIN 4 YL)ETHYL] 1 (4 METHOXYPHENYL)BUTANE 1,3 DIONE;
2 [2 (1 BENZYLPIPERIDIN 4 YL)ETHYL] 1 [3 METHOXY 4 (METHOXYMETHOXY)PHENYL]BUTANE 1,3 DIONE;
4 (1 BENZYLPIPERIDIN 4 YL) 1 (3 HYDROXY 4 METHOXYPHENYL)BUTANE 1,3 DIONE;
4 (1 BENZYLPIPERIDIN 4 YL) 1 (3,4 DIMETHOXYPHENYL)BUTANE 1,3 DIONE;
4 (1 BENZYLPIPERIDIN 4 YL) 1 (4 METHOXYPHENYL)BUTANE 1,3 DIONE;
4 (1 BENZYLPIPERIDIN 4 YL) 1 [4 METHOXY 3 (METHOXYMETHOXY)PHENYL]BUTANE 1,3 DIONE;
ACETYLCHOLINESTERASE;
AMYLOID BETA PROTEIN[1-42];
ANTIOXIDANT;
CHOLINESTERASE;
COPPER COMPLEX;
CURCUMIN;
DONEPEZIL;
GALANTAMINE;
METAL CHELATE;
TACRINE;
UNCLASSIFIED DRUG;
AMYLOID BETA PROTEIN;
AMYLOID BETA-PROTEIN (1-42);
CHOLINESTERASE INHIBITOR;
INDAN DERIVATIVE;
LIGAND;
PEPTIDE FRAGMENT;
PIPERIDINE DERIVATIVE;
PROTEIN AGGREGATE;
ALZHEIMER DISEASE;
ANTIOXIDANT ACTIVITY;
ARTICLE;
BLOOD BRAIN BARRIER;
DRUG DESIGN;
DRUG DETERMINATION;
DRUG PENETRATION;
DRUG POTENCY;
DRUG SCREENING;
DRUG SELECTIVITY;
DRUG SYNTHESIS;
DRUG TARGETING;
ENZYME INHIBITION;
HUMAN;
IC50;
IN VITRO STUDY;
MEMBRANE PERMEABILITY;
PROTEIN AGGREGATION;
STOICHIOMETRY;
ANALOGS AND DERIVATIVES;
ANIMAL;
CHEMISTRY;
DRUG EFFECTS;
ELECTROPHORUS;
ENZYMOLOGY;
METABOLISM;
MOLECULAR DOCKING;
MOLECULARLY TARGETED THERAPY;
PIG;
ACETYLCHOLINESTERASE;
ALZHEIMER DISEASE;
AMYLOID BETA-PEPTIDES;
ANIMALS;
BLOOD-BRAIN BARRIER;
CHOLINESTERASE INHIBITORS;
CURCUMIN;
DRUG DESIGN;
ELECTROPHORUS;
HUMANS;
INDANS;
LIGANDS;
MOLECULAR DOCKING SIMULATION;
MOLECULAR TARGETED THERAPY;
PEPTIDE FRAGMENTS;
PIPERIDINES;
PROTEIN AGGREGATES;
SWINE;
|
EID: 85018675095
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2017.02.048 Document Type: Article |
Times cited : (55)
|
References (28)
|